US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health in Tech

0.8207

-0.0318-3.73%

Pre-market: 0.7300-0.0907-11.05%09:22 EDT

Volume:6.16M

Turnover:6.01M

Market Cap:53.78M

PE:-12.57

High:0.8636

Open:0.8500

Low:0.8000

Close:0.8525

52wk High:4.02

52wk Low:0.7749

Shares:65.53M

Float Shares:20.30M

Volume Ratio:171.84

T/O Rate:30.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0653

EPS(LYR):0.0200

ROE:-21.91%

ROA:-12.72%

PB:2.75

PE(LYR):41.04

Loading ...

Overview Company News Filings

Health In Tech sees 2026 revenue $33M, consensus $41.19M

Health in Tech Forecasts 2026 Revenue About $33 Million, Roughly in Line with 2025

Health in Tech - Updates Fy2026 Revenue Outlook to About $33 Mln

THOMSON REUTERS

Health in Tech Launches Hitrix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance

THOMSON REUTERS

Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference

Health in Tech Director Timothy Hayes Sells 17,730 Common Shares for $16,243.80

Health in Tech Files for Offering of up to 29.5 Mln Class a Shares by Selling Stockholder

Health in Tech - Prospectus Relates to Resale of up to 29,532,889 Class a Common Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS

Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia

Health In Tech price target lowered to $3 from $4 at Maxim

Maxim Group Sticks to Their Buy Rating for Health In Tech, Inc. Class A (HIT)

Health in Tech Q2 FY26 Net Loss Widens to $2.5 Million; Revenue Falls to $8.1 Million

Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate

Benzinga Earnings

Health in Tech - Reaffirms Full-Year 2026 Revenue Guidance of $45 Mln to $50 Mln

THOMSON REUTERS

Press Release: Health in Tech Reports Second Quarter 2026 Financial Results

Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process

Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Health in Tech to Report Q2 2026 Results, Host Earnings Call

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/HIT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIT\",,,,,undefined,":{"symbol":"HIT","market":"US","secType":"STK","nameCN":"Health in Tech","latestPrice":0.8207,"timestamp":1790798400000,"preClose":0.8525,"halted":0,"volume":6158918,"hourTrading":{"tag":"盘前","latestPrice":0.73,"preClose":0.8207,"latestTime":"09:22 EDT","volume":39567,"amount":29860.344426,"timestamp":1790860976306,"change":-0.0907,"changeRate":-0.110515,"amplitude":0.151822},"delay":0,"changeRate":-0.037302052785923814,"floatShares":20299100,"shares":65529600,"eps":-0.0653,"marketStatus":"Pre-Mkt","change":-0.0318,"latestTime":"10-01 09:24:03 EDT","open":0.850001,"high":0.8636,"low":0.8,"amount":6014904.26676272,"amplitude":0.074604,"askPrice":0.88,"askSize":1500,"bidPrice":0.6777,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.0653,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"listingDate":1734930000000,"exchange":"NASDAQ","adjPreClose":0.8207,"preHourTrading":{"tag":"盘前","latestPrice":0.73,"preClose":0.8207,"latestTime":"09:22 EDT","volume":39567,"amount":29860.344426,"timestamp":1790860976306,"change":-0.0907,"changeRate":-0.110515,"amplitude":0.151822},"postHourTrading":{"tag":"盘后","latestPrice":0.79,"preClose":0.8207,"latestTime":"19:59 EDT","volume":6107440,"amount":5818515.885181,"timestamp":1790812780606,"change":-0.0307,"changeRate":-0.037407,"amplitude":0.402096},"volumeRatio":171.8382739832076},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIT\",,,,,undefined,":{"symbol":"HIT","floatShares":20299100,"roa":"-12.72%","roe":"-21.91%","lyrEps":0.02,"volumeRatio":171.8382739832076,"shares":65529600,"dividePrice":0,"high":0.8636,"amplitude":0.074604,"preClose":0.8525,"low":0.8,"week52Low":0.7749,"pbRate":"2.75","psRate":"1.64","week52High":4.02,"institutionHeld":0,"latestPrice":0.8207,"committee":-0.986755,"eps":-0.0653,"divideRate":0,"volume":6158918,"delay":0,"ttmEps":-0.0653,"open":0.850001,"prevYearClose":1.59,"prevWeekClose":0.86,"prevMonthClose":0.8207,"prevQuarterClose":0.8207,"fiveDayClose":0.8825,"twentyDayClose":0.968,"sixtyDayClose":1.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"HIT","fiscalQuarterEnding":"2026/06","expectedEps":-0.03,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2026-05-13","symbol":"HIT","fiscalQuarterEnding":"2026/03","expectedEps":-0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-03-25","symbol":"HIT","fiscalQuarterEnding":"2025/12","expectedEps":-0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-04-14","symbol":"HIT","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1744603200000,"reportTimeType":"post","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1778817600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HIT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HIT","date":"2026-09-30","current":-12.568147,"percent":0.204082,"low":-99.750333,"twenty":-14.236586,"median":56.441063,"eighty":121.796762,"high":221.999544,"avg":55.622512,"sd":76.836403,"marketCap":55868295},"quantilePoints":[{"date":"2024-12-27","current":157.125683,"twenty":141.889253,"median":160.399135,"eighty":163.672587,"marketCap":285486210},{"date":"2025-01-03","current":155.340164,"twenty":156.054372,"median":159.431979,"eighty":163.196448,"marketCap":282242048},{"date":"2025-01-10","current":163.077413,"twenty":154.387887,"median":159.134392,"eighty":162.958378,"marketCap":296300081},{"date":"2025-01-17","current":169.029144,"twenty":154.625956,"median":159.506375,"eighty":163.672587,"marketCap":307113953},{"date":"2025-01-24","current":153.257058,"twenty":154.447404,"median":161.291894,"eighty":169.029144,"marketCap":278457193},{"date":"2025-01-31","current":183.90847,"twenty":154.447404,"median":161.887067,"eighty":169.624317,"marketCap":334148632},{"date":"2025-02-07","current":158.018442,"twenty":154.447404,"median":161.291894,"eighty":169.029144,"marketCap":287108290},{"date":"2025-02-14","current":176.766393,"twenty":155.340164,"median":162.779827,"eighty":171.409836,"marketCap":321171986},{"date":"2025-02-21","current":200.275728,"twenty":156.768579,"median":163.672587,"eighty":173.909563,"marketCap":363886779},{"date":"2025-02-28","current":207.417805,"twenty":157.83989,"median":165.458105,"eighty":181.765847,"marketCap":376863425},{"date":"2025-03-07","current":212.774362,"twenty":158.73265,"median":167.690004,"eighty":197.061793,"marketCap":386595909},{"date":"2025-03-14","current":32.734517,"twenty":157.83989,"median":169.029144,"eighty":199.323452,"marketCap":59476293},{"date":"2025-03-21","current":56.458248,"twenty":154.030783,"median":165.606898,"eighty":197.656967,"marketCap":37853957},{"date":"2025-03-28","current":55.854885,"twenty":145.69836,"median":163.672587,"eighty":197.061793,"marketCap":37449416},{"date":"2025-04-04","current":54.649326,"twenty":57.938837,"median":162.779827,"eighty":197.002276,"marketCap":36641116},{"date":"2025-04-11","current":52.572179,"twenty":55.748991,"median":161.291894,"eighty":191.050546,"marketCap":35248437},{"date":"2025-04-17","current":34.087191,"twenty":54.660513,"median":159.506375,"eighty":186.170128,"marketCap":36423288},{"date":"2025-04-25","current":33.769958,"twenty":52.396232,"median":159.134392,"eighty":182.301503,"marketCap":36084314},{"date":"2025-05-02","current":31.160461,"twenty":45.578303,"median":157.125683,"eighty":179.087568,"marketCap":33295981},{"date":"2025-05-09","current":39.930417,"twenty":35.548508,"median":154.298611,"eighty":177.659153,"marketCap":42666968},{"date":"2025-05-16","current":34.281623,"twenty":35.548508,"median":153.257058,"eighty":177.123497,"marketCap":36631046},{"date":"2025-05-23","current":33.258292,"twenty":34.731889,"median":135.699453,"eighty":174.62377,"marketCap":35537582},{"date":"2025-05-30","current":33.427142,"twenty":34.164964,"median":62.92533,"eighty":173.07632,"marketCap":35718004},{"date":"2025-06-06","current":32.245193,"twenty":33.613388,"median":57.019717,"eighty":172.302595,"marketCap":34455053},{"date":"2025-06-13","current":30.699962,"twenty":33.084325,"median":56.156566,"eighty":171.409836,"marketCap":32803922},{"date":"2025-06-20","current":30.699962,"twenty":32.521493,"median":55.626806,"eighty":171.290801,"marketCap":32803922},{"date":"2025-06-27","current":40.953749,"twenty":32.521493,"median":54.649326,"eighty":170.576594,"marketCap":43760432},{"date":"2025-07-03","current":43.537662,"twenty":32.644293,"median":53.403037,"eighty":169.624317,"marketCap":46521429},{"date":"2025-07-11","current":56.794929,"twenty":32.734517,"median":52.352245,"eighty":169.029144,"marketCap":60687256},{"date":"2025-07-18","current":61.399923,"twenty":33.002459,"median":53.724933,"eighty":166.350865,"marketCap":65607844},{"date":"2025-07-25","current":80.355571,"twenty":33.207125,"median":54.437195,"eighty":165.755692,"marketCap":109376548},{"date":"2025-08-01","current":85.740222,"twenty":33.258292,"median":55.423164,"eighty":165.458105,"marketCap":116705904},{"date":"2025-08-08","current":95.681118,"twenty":33.427142,"median":55.842666,"eighty":164.267759,"marketCap":130237023},{"date":"2025-08-15","current":134.225003,"twenty":33.509008,"median":56.458248,"eighty":163.672587,"marketCap":182701302},{"date":"2025-08-22","current":141.681948,"twenty":33.769958,"median":56.907323,"eighty":163.672587,"marketCap":192851375},{"date":"2025-08-29","current":115.996916,"twenty":33.826241,"median":58.296911,"eighty":163.077413,"marketCap":157890014},{"date":"2025-09-05","current":116.411191,"twenty":33.871267,"median":61.399923,"eighty":162.601275,"marketCap":158453907},{"date":"2025-09-12","current":115.582641,"twenty":33.960297,"median":65.505359,"eighty":162.006102,"marketCap":157326121},{"date":"2025-09-19","current":146.238969,"twenty":34.065701,"median":68.343655,"eighty":161.410929,"marketCap":199054197},{"date":"2025-09-26","current":136.296377,"twenty":34.242737,"median":75.592225,"eighty":161.291894,"marketCap":185520767},{"date":"2025-10-03","current":145.41042,"twenty":34.400329,"median":82.840795,"eighty":159.863479,"marketCap":197926411},{"date":"2025-10-10","current":142.510497,"twenty":34.597833,"median":90.503568,"eighty":159.506375,"marketCap":193979161},{"date":"2025-10-17","current":142.096223,"twenty":34.762589,"median":102.722585,"eighty":159.387341,"marketCap":193415268},{"date":"2025-10-24","current":124.28241,"twenty":34.80557,"median":108.747109,"eighty":159.000478,"marketCap":169167873},{"date":"2025-10-31","current":108.125697,"twenty":35.001026,"median":110.197071,"eighty":158.196994,"marketCap":147176049},{"date":"2025-11-07","current":115.996916,"twenty":35.126896,"median":111.232757,"eighty":157.304235,"marketCap":157890014},{"date":"2025-11-14","current":65.041128,"twenty":35.682565,"median":110.611345,"eighty":156.370386,"marketCap":88531186},{"date":"2025-11-21","current":49.494631,"twenty":36.438807,"median":109.575659,"eighty":155.508444,"marketCap":71136010},{"date":"2025-11-28","current":60.185471,"twenty":37.969712,"median":108.125697,"eighty":154.804508,"marketCap":86501388},{"date":"2025-12-05","current":50.286545,"twenty":39.123499,"median":102.722585,"eighty":154.268852,"marketCap":72274186},{"date":"2025-12-12","current":41.971447,"twenty":39.670818,"median":90.503568,"eighty":153.792714,"marketCap":60323336},{"date":"2025-12-19","current":53.850158,"twenty":40.532136,"median":85.740222,"eighty":153.376093,"marketCap":77395978},{"date":"2025-12-26","current":60.185471,"twenty":40.941469,"median":80.355571,"eighty":152.899954,"marketCap":86501388},{"date":"2026-01-02","current":62.95717,"twenty":41.131809,"median":75.81227,"eighty":152.364298,"marketCap":90485004},{"date":"2026-01-09","current":63.353127,"twenty":41.869528,"median":71.272268,"eighty":151.636362,"marketCap":91054092},{"date":"2026-01-16","current":55.433987,"twenty":41.971447,"median":68.343655,"eighty":148.393197,"marketCap":79672331},{"date":"2026-01-23","current":58.601643,"twenty":41.971447,"median":67.881746,"eighty":147.067519,"marketCap":84225035},{"date":"2026-01-30","current":47.118888,"twenty":41.971447,"median":66.520784,"eighty":146.238969,"marketCap":67721481},{"date":"2026-02-06","current":39.591745,"twenty":41.971447,"median":65.041128,"eighty":145.824695,"marketCap":56903117},{"date":"2026-02-13","current":42.763361,"twenty":41.971447,"median":63.551106,"eighty":145.824695,"marketCap":61461512},{"date":"2026-02-20","current":42.458474,"twenty":41.971447,"median":63.24105,"eighty":145.493275,"marketCap":61023314},{"date":"2026-02-27","current":53.454201,"twenty":42.254301,"median":62.721688,"eighty":145.079,"marketCap":76826890},{"date":"2026-03-06","current":66.520784,"twenty":42.431782,"median":62.443472,"eighty":144.664725,"marketCap":95606797},{"date":"2026-03-13","current":76.815667,"twenty":42.702384,"median":63.128972,"eighty":143.919031,"marketCap":110403087},{"date":"2026-03-20","current":79.19141,"twenty":42.763361,"median":63.551106,"eighty":143.090481,"marketCap":113817616},{"date":"2026-03-27","current":72.649053,"twenty":42.763361,"median":64.540999,"eighty":142.593352,"marketCap":92906660},{"date":"2026-04-02","current":72.794568,"twenty":42.763361,"median":65.041128,"eighty":142.510497,"marketCap":93092751},{"date":"2026-04-10","current":71.769293,"twenty":42.834982,"median":66.322806,"eighty":142.261933,"marketCap":91781586},{"date":"2026-04-17","current":73.819844,"twenty":42.993249,"median":67.312698,"eighty":141.847658,"marketCap":94403917},{"date":"2026-04-24","current":77.408308,"twenty":43.122362,"median":67.688423,"eighty":141.681948,"marketCap":98992996},{"date":"2026-05-01","current":74.332482,"twenty":43.386324,"median":67.929451,"eighty":140.936253,"marketCap":95059500},{"date":"2026-05-08","current":80.448884,"twenty":43.537662,"median":68.725663,"eighty":139.941994,"marketCap":102881412},{"date":"2026-05-15","current":-99.750333,"twenty":43.537662,"median":68.80861,"eighty":139.113444,"marketCap":80601361},{"date":"2026-05-22","current":-74.812749,"twenty":42.834982,"median":68.518561,"eighty":138.284895,"marketCap":60451020},{"date":"2026-05-29","current":-79.273129,"twenty":42.763361,"median":67.905598,"eighty":137.622056,"marketCap":64055146},{"date":"2026-06-05","current":-81.097832,"twenty":41.971447,"median":67.66819,"eighty":136.959216,"marketCap":65529562},{"date":"2026-06-12","current":-85.963701,"twenty":41.682913,"median":67.11472,"eighty":136.544941,"marketCap":69461335},{"date":"2026-06-18","current":-85.963701,"twenty":40.13099,"median":66.322806,"eighty":136.213522,"marketCap":69461335},{"date":"2026-06-26","current":-78.656787,"twenty":37.052807,"median":65.041128,"eighty":135.799247,"marketCap":63557122},{"date":"2026-07-02","current":-85.963701,"twenty":35.049122,"median":64.353376,"eighty":135.467827,"marketCap":69461335},{"date":"2026-07-10","current":-88.396636,"twenty":34.430006,"median":63.551106,"eighty":134.225003,"marketCap":71427222},{"date":"2026-07-17","current":-86.774679,"twenty":33.882524,"median":63.128972,"eighty":134.225003,"marketCap":70116631},{"date":"2026-07-24","current":-85.98016,"twenty":33.427142,"median":62.443472,"eighty":132.982179,"marketCap":69474635},{"date":"2026-07-31","current":-84.357893,"twenty":32.948871,"median":61.429682,"eighty":132.982179,"marketCap":68163793},{"date":"2026-08-07","current":-90.846963,"twenty":32.464186,"median":60.185471,"eighty":132.982179,"marketCap":73407162},{"date":"2026-08-14","current":-85.98016,"twenty":32.12751,"median":60.185471,"eighty":131.6565,"marketCap":69474635},{"date":"2026-08-21","current":-16.924219,"twenty":31.714084,"median":58.601643,"eighty":127.348043,"marketCap":66845351},{"date":"2026-08-28","current":-16.59569,"twenty":31.190138,"median":58.057586,"eighty":125.359524,"marketCap":65547764},{"date":"2026-09-04","current":-16.582416,"twenty":30.699962,"median":57.413772,"eighty":124.44812,"marketCap":65495337},{"date":"2026-09-11","current":-15.444179,"twenty":30.434918,"median":57.413772,"eighty":124.28241,"marketCap":60999659},{"date":"2026-09-18","current":-13.439821,"twenty":24.521129,"median":56.906372,"eighty":123.536716,"marketCap":53083072},{"date":"2026-09-25","current":-14.164908,"twenty":-14.128073,"median":56.506539,"eighty":122.293892,"marketCap":55946937},{"date":"2026-09-30","current":-14.144997,"twenty":-14.236586,"median":56.441063,"eighty":121.796762,"marketCap":55868295}],"updateTime":1790858442922},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672782901","title":"Health In Tech sees 2026 revenue $33M, consensus $41.19M","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782901","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782901?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:11","pubTimestamp":1790799075,"startTime":"0","endTime":"0","summary":"Health In Tech (HIT) said when announcing the launch of HitRix, its new AI-powered platform, “The Company also updated its full-year 2026 revenue o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-sees-2026-revenue-33m-consensus-41-19m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-sees-2026-revenue-33m-consensus-41-19m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","BK4173","AIPO","HIT","VTHR","AGIX","QTOC","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672784056","title":"Health in Tech Forecasts 2026 Revenue About $33 Million, Roughly in Line with 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2672784056","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672784056?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:00","pubTimestamp":1790798451,"startTime":"0","endTime":"0","summary":"Health In Tech forecasts 2026 revenue about $33 million, roughly in line with 2025Health In Tech forecast full-year 2026 revenue of about $33 million, roughly in line with 2025.Outlook reflects timing","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL2MxfBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672784036","title":"Health in Tech - Updates Fy2026 Revenue Outlook to About $33 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2672784036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672784036?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:00","pubTimestamp":1790798401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA4C35CH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672078408","title":"Health in Tech Launches Hitrix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672078408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672078408?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:00","pubTimestamp":1790798401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA4C35CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669519332","title":"Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2669519332","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669519332?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:30","pubTimestamp":1790022600,"startTime":"0","endTime":"0","summary":"PONTE VEDRA, Fla., Sept.  21, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/21/3365872/0/en/cadrenal-therapeutics-to-participate-in-the-lytham-partners-fall-2026-investor-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","IE0031619046.USD","IE00B19Z4B17.USD","BK4539","IE00B7SZL793.SGD","KD","HIT","LENZ","IE00B66KJ199.SGD","BK4139","BK4134","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666157074","title":"Health in Tech Director Timothy Hayes Sells 17,730 Common Shares for $16,243.80","url":"https://stock-news.laohu8.com/highlight/detail?id=2666157074","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666157074?lang=en_us&edition=fundamental","pubTime":"2026-09-12 09:15","pubTimestamp":1789175714,"startTime":"0","endTime":"0","summary":"Health in Tech director Timothy Hayes sells 17,730 common shares for $16,243.80Timothy Hayes, director, sold 17,730 shares of Class A common stock on Sept. 9-11.Sales totaled about $16,240, priced at ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260912:nNDL9WpjSd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Health in Tech Director Timothy Hayes Sells 17,730 Common Shares for $16,243.80","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664358882","title":"Health in Tech Files for Offering of up to 29.5 Mln Class a Shares by Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2664358882","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664358882?lang=en_us&edition=fundamental","pubTime":"2026-09-04 23:09","pubTimestamp":1788534594,"startTime":"0","endTime":"0","summary":"BRIEF-Health In Tech Files For Offering Of Up To 29.5 Mln Class A Shares By Selling StockholderSept 4 (Reuters)-Health In Tech IncHIT.O:HEALTH IN TECH - PROSPECTUS RELATES TO RESALE OF UP TO 29,532,889 CLASS A COMMON SHARES BY SELLING STOCKHOLDER  - SEC FILINGFurther company coverage:HIT.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44W0T5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664358883","title":"Health in Tech - Prospectus Relates to Resale of up to 29,532,889 Class a Common Shares by Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664358883","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664358883?lang=en_us&edition=fundamental","pubTime":"2026-09-04 23:08","pubTimestamp":1788534538,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44W0T5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664941877","title":"Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664941877","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664941877?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"PONTE VEDRA, Fla., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355832/0/en/cadrenal-therapeutics-to-participate-in-h-c-wainwright-s-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","IE0031619046.USD","BK4173","BK4134","IE00B19Z4B17.USD","BK4539","HIT","KD","IE00B7SZL793.SGD","BK4007","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008480","title":"Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008480","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008480?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177600,"startTime":"0","endTime":"0","summary":"FDA Alignment on Primary Endpoint and Path Forward for Phase 3 Registration Study CAD-1005 Targets a Significant Unmet Need, with Approximately 50,000 Confirmed Acute HIT Diagnoses Annually in the U.S","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/31/3353254/0/en/cadrenal-therapeutics-announces-positive-outcome-from-fda-type-d-meeting-for-phase-3-registration-study-of-cad-1005-in-heparin-induced-thrombocytopenia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","IE0031619046.USD","BK4613","BK4539","HIT","SAP","IE00B7SZL793.SGD","BK4134","BK4173","KD","IE00B66KJ199.SGD","LABU","BK4585","IE00B19Z4B17.USD","BK4139","BK4007","BK4588","LENZ","BK4528"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659172071","title":"Health In Tech price target lowered to $3 from $4 at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2659172071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659172071?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:21","pubTimestamp":1786886504,"startTime":"0","endTime":"0","summary":"Maxim lowered the firm’s price target on Health In Tech (HIT) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model af...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-price-target-lowered-to-3-from-4-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-price-target-lowered-to-3-from-4-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315144","title":"Maxim Group Sticks to Their Buy Rating for Health In Tech, Inc. Class A (HIT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315144?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:55","pubTimestamp":1786712157,"startTime":"0","endTime":"0","summary":"In a report released today, Allen Klee from Maxim Group reiterated a Buy rating on Health In Tech, Inc. Class A, with a price target of $3.00. Klee...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-health-in-tech-inc-class-a-hit-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-health-in-tech-inc-class-a-hit-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659709167","title":"Health in Tech Q2 FY26 Net Loss Widens to $2.5 Million; Revenue Falls to $8.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659709167","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659709167?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:37","pubTimestamp":1786653463,"startTime":"0","endTime":"0","summary":"Health In Tech Q2 FY26 net loss widens to $2.5 million; revenue falls to $8.1 millionHealth In Tech Q2 revenue fell to $8.1 million from $9.3 million a year earlier.Net results swung to a $2.5 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6CGJty:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659316746","title":"Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659316746","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659316746?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:31","pubTimestamp":1786653094,"startTime":"0","endTime":"0","summary":"Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is a 500 percent decrease over earnings of $0.01 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61194685/health-tech-q2-eps-0-04-misses-0-03-estimate-sales-8-057m-beat-7-547m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616709","title":"Health in Tech - Reaffirms Full-Year 2026 Revenue Guidance of $45 Mln to $50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616709?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:30","pubTimestamp":1786653002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA5CDRDP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167229","title":"Press Release: Health in Tech Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167229","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167229?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:30","pubTimestamp":1786653000,"startTime":"0","endTime":"0","summary":"Contracted Revenue of $32.3 Million as of June 30, 2026Pipeline Revenue of $66.3 Million as of July 31, 2026Distribution Partners Grew 19.9% Year Over YearSTUART, Fla., Aug. 13, 2026 /PRNewswire/ -- Health In Tech, Inc.  , an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three and six months ended June 30, 2026.Second Quarter and First-Half 2026 Highlights-- Distribution Partners, including brokers, third-party administrators.  and agencies, reached 933 as of June 30, 2026, an increase of. -- Q2 2026 Revenue was $8.1 million, compared with $9.3 million in Q2 2025.First-half 2026 revenue was $16.8 million, compared with $17.3 million in. -- Contracted Revenue1 totaled $32.3 million for first-half 2026, of which. $17.3 million was recognized as GAAP revenue in first-half 2026. The. remaining $14.0 million and $1.0 million are expected to be recognized as. GAAP revenue in second-half 2026 and in 2027, respectively.-- Pipeline Revenue2 was $","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MDST","EMLP","TPZ","TNGY","BK4585","BK4561","EIPI","EIPX","UMI","BK4590","AMZA","USAI","HIT","BK4144","ENFR","BK4581","MLPA","AMLP","BK4173","ET"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659952921","title":"Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2659952921","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659952921?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"Late-breaking Phase 2 CAD-1005 data presented at ISTH support a late-stage portfolio organized around preoperative safety, orphan regulatory acceleration, and postoperative shieldingPONTE VEDRA, Fla.,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344960/0/en/cadrenal-therapeutics-reports-second-quarter-2026-financial-results-provides-a-corporate-update-on-the-cardiac-acute-critical-care-franchise-and-the-strategic-partnering-process.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","BK4539","IE0031619046.USD","IE00B66KJ199.SGD","KD","BK4139","BK4173","IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4007","CACC","BK4166","LENZ","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943723","title":"Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943723","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943723?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:33","pubTimestamp":1786480386,"startTime":"0","endTime":"0","summary":"Health In Tech Inc <HIT.OQ> expected to post a loss of2cents a share - Earnings PreviewHealth In Tech IncHIT.OQHIT.Ois expected to  show a fall in quarterly revenue when it reports  results on August ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44823J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656230130","title":"Health in Tech to Report Q2 2026 Results, Host Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2656230130","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656230130?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:05","pubTimestamp":1785787551,"startTime":"0","endTime":"0","summary":"Health In Tech to report Q2 2026 results, host earnings callHealth In Tech schedules second-quarter 2026 results release for Aug. 13, 2026, following the market close.Earnings conference call set for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL5KvTYb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656379102","title":"Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2656379102","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656379102?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:30","pubTimestamp":1785760200,"startTime":"0","endTime":"0","summary":"UrgentNeed for Novel Targets - Recent clinical failure of a competing mechanism highlights urgent need for novel upstream targets, such as 12-LOX, that are being studied to address the root causes of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337506/0/en/Cadrenal-Therapeutics-Solidifies-Multi-Indication-Strategy-for-CAD-1005-in-Cardiac-Acute-Critical-Care-Following-Competitor-s-Phase-3-Discontinuation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","LENZ","LU0149725797.USD","CACC","CSA","HIT","BK4134","IE00B66KJ199.SGD","BK4007","IE00BHPRN162.USD","BK4173","BK4539","IE0031619046.USD","KD","IE00B19Z4B17.USD","BK4139","BK4166"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}